scispace - formally typeset
Q

Qing Zhang

Researcher at Nanjing University

Publications -  60
Citations -  2111

Qing Zhang is an academic researcher from Nanjing University. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 18, co-authored 58 publications receiving 1662 citations. Previous affiliations of Qing Zhang include Wenzhou Medical College & University of Texas Southwestern Medical Center.

Papers
More filters
Journal ArticleDOI

The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control.

TL;DR: Evidence is provided that the TEAD/TEF family transcription factor Scalloped (Sd) acts together with the coactivator Yorkie (Yki) to regulate Hpo pathway-responsive genes, forming a transcriptional complex whose activity is inhibited by Hpo signaling.
Journal ArticleDOI

A Hedgehog-Induced BTB Protein Modulates Hedgehog Signaling by Degrading Ci/Gli Transcription Factor

TL;DR: Evidence is provided that HIB prevents aberrant Hh signaling posterior to the morphogenic furrow, which is essential for normal eye development, and inactivating HIB results in Ci accumulation and enhanced pathway activity.
Journal ArticleDOI

Phosphorylation by Double-Time/CKIε and CKIα Targets Cubitus Interruptus for Slimb/β-TRCP-Mediated Proteolytic Processing

TL;DR: It is shown that Double-time (DBT)/CKIe and CKIα act in conjunction to promote Ci processing and it is proposed that phosphorylation of Ci by CKI creates multiple Slimb/β-TRCP binding sites that act cooperatively to recruit SCF Slimb-TR CP.
Journal ArticleDOI

Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation

TL;DR: This work demonstrates that SPOP, functioning as an E3 ubiquitin ligase substrate-binding protein, promotes ubiquitination and proteasome degradation of wild-type ERG by recognizing a degron motif at the N terminus of ERG and suggests that overcoming ERG resistance to SPOP-mediated degradation represents a viable strategy for treatment of prostate cancer.
Journal ArticleDOI

Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.

TL;DR: Self-assembled tumor-targeting hyaluronic acid-IR-780 nanoparticles for photothermal ablation in over-expressing CD44 (the receptor for HA) bladder cancer are developed, which show high tumor selectivity, high treatment efficacy, good bioavailability, and excellent biocompatibility.